Clinical trial
Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases: A Randomised, Placebo-controlled Trial
NCT03017352 is registered in ClinicalTrials.gov with Filip Krag Knop as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases: A Randomised, Placebo-controlled Trial
- Lead sponsor
- Filip Krag Knop
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2016
- Completion date
- June 30, 2019
- Enrollment
- 108 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.